Islam Sadek/X
Sep 14, 2026, 07:54
Islam Sadek: SOHO 2026 Highlights Advances in Hematologic Malignancies
Islam Sadek, Vice President and Head US Medical Affairs at Takeda Oncology, shared a post on X:
“Just wrapped up an incredible few days at SOHO 2026.
One of best hematology meetings, bringing together cutting-edge science, research and clinical updates to advance care for patients with hematologic malignancies.
Outstanding meeting and organization.
Looking forward to SOHO 2027!”

Stay updated with Hemostasis Today.
-
Sep 14, 2026, 15:22Meral Kayikcioglu: Why Do Women and Men Differ in LDL-C Management?
-
Sep 14, 2026, 15:22James Crowley: The Complex Role of CRP in Cardiovascular Risk and Atherosclerosis
-
Sep 14, 2026, 15:16Factor XIII Deficiency An Often-Missed Bleeding Disorder
-
Sep 14, 2026, 15:07Raffaele Piccolo: Heparin Against Jellyfish Venom?
-
Sep 14, 2026, 15:06Contemporary Research in Thrombosis and Hemostasis – Seminars in Thrombosis and Hemostasis
-
Sep 14, 2026, 15:00Obi Light Ogbonnia: Improving Outcomes for People Living with Sickle Cell Disease in Nigeria
-
Sep 14, 2026, 14:57Closing the Global Gap in NCD Prevention and Care – ISTH
-
Sep 14, 2026, 14:54Petter Brodin: A New Axis of Functional Variation in Human Immune Cells
-
Sep 14, 2026, 14:50Michael Meneghini: The Metabolic Picture Behind Cardiovascular Risk